Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Energies for life
Tél. : +212 5 22 43 70 40 - Fax: +212 5 22 33 41 09 - www.sothema.com / www.sothema-tollmanufacturing.com
WE OFFER YOU A WIDE RANGE OF PRODUCTS
SOTHEMA EXPORT
MOROCCAN PHARMACEUTICAL LABORATORY
We, at SOTHEMA, respect the needs and expectations of our customers. We commit to provide the products our customers demand, with the service they expect, from the people they can depend on
Why SOTHEMASOTHEMA is a pharmaceutical com-pany focused on improving the lives of patients through the manufactur-ing and commercialization of Specialty Pharmaceuticals and Branded generic products.
SOTHEMA is creating innovative generic products by improving and expanding the use of known compounds, and ag-gressively adding to our pharmaceutical portfolio through development, licens-ing, acquisitions, and collaborations.
About SOTHEMA SOTHEMA was formed in 1976 and is a Moroccan leading pharmaceutical laboratories. It is privately-held com-pany specializing in the manufacture, the sales & marketing of effective high-quality generic and brand pharma-ceutical products.
SOTHEMA is certified by many emi-nent International agencies. With glo-bal presence, the company products have achieved notoriety in Morocco and abroad.
Mag
nesi
um S
ulfa
t 7H
2O &
Yea
st
1,2
g &
0,1
g /
10 m
l dri
nkab
le a
mpu
les
Am
poul
e 30
Dri
nkab
le a
mpo
ules
M
AG
NES
IUM
Vita
B12
10
00 M
CG
/1m
l In
ject
able
Sol
utio
n B
ox o
f 10
Vita
min
eV
ita B
6
100
mg/
2ml
Inje
ctab
le S
olut
ion
Box
of 1
0 V
itam
ine
Vita
B6
25
0 m
g/2m
l In
ject
able
Sol
utio
n B
ox o
f 10
Vita
min
eSu
lfate
de
Mag
nési
um
1 g/
10m
l In
ject
able
Sol
utio
n B
ox o
f 10
Ant
i-m
agne
sem
iaSu
lfate
de
Mag
nési
um
3 g/
10m
l In
ject
able
Sol
utio
n B
ox o
f 10
Ant
i-m
agne
sem
iaM
agne
sium
(gly
cero
phos
phat
e ac
id) /
Pyr
idox
ine
HC
l or V
itam
in B
6 50
0 m
g / 1
25m
g D
RIN
KA
BLE
AM
POU
LE
20 D
rink
able
am
poul
es
MA
GN
ESIU
M D
EFIC
IEN
CY
TR
EATE
MEN
TH
ospi
tal p
rodu
cts
of 1
0 m
l
Adr
enal
ine
1 m
g/ 1
ml
Inje
ctab
le S
olut
ion
Box
of 1
0 C
ardi
ac s
timul
ant &
Car
diot
onic
hor
mon
Atr
opin
e Su
lfate
0,
25 m
g/1m
l In
ject
able
Sol
utio
n B
ox o
f 10
Ant
ispa
smod
ic a
ntic
holin
ergi
c, a
ntia
rrhy
thm
icA
trop
ine
Sulfa
te
0,5
mg/
1ml
Inje
ctab
le S
olut
ion
Box
of 1
0 A
ntis
pasm
odic
ant
icho
liner
gic,
ant
iarr
hyth
mic
Atr
opin
e Su
lfate
1
mg/
1ml
Inje
ctab
le S
olut
ion
Box
of 1
0 A
ntis
pasm
odic
ant
icho
liner
gic,
ant
iarr
hyth
mic
Cal
cium
Chl
orur
e
1 g/
10m
l In
ject
able
Sol
utio
n B
ox o
f 10
Any
i - h
ypoc
alce
mia
& A
nti-
hypo
kale
mia
Ephe
dirn
e 10
mg/
1ml
Inje
ctio
n so
lutio
n B
ox o
f 10
Car
diac
Sym
path
omim
etic
Ephe
dirn
e 30
mg/
1ml
Inje
ctio
n so
lutio
n B
ox o
f 10
Car
diac
Sym
path
omim
etic
Ephe
drin
e
50 m
g/1m
l In
ject
ion
solu
tion
Box
of 1
0 C
ardi
ac S
ympa
thom
imet
icG
luco
se
5%
Solu
tion
for
inje
ctio
n Po
che
of 1
00 /
250
/ 500
/ 10
00 m
l SO
LUTI
ON
FO
R IN
FUSI
ON
Glu
cose
10
%
Solu
tion
for
inje
ctio
n Po
che
of 5
00 m
l SO
LUTI
ON
FO
R IN
FUSI
ON
Man
nito
l 20
%
Perf
usio
n So
lutio
n Po
che
of 2
50 &
500
ml
Osm
otic
Diu
retic
sG
LUC
OSE
, PO
TASS
IUM
AN
D
SOD
IUM
CH
LOR
IDES
10
%
POC
HE
Poch
e of
250
, 500
, 100
0 &
200
0 m
l M
ass
solu
tion
GLU
CO
SE, P
OTA
SSIU
M A
ND
SO
DIU
M C
HLO
RID
ES
5%
POC
HE
Poch
e of
250
, 500
& 2
000
ml
Mas
s so
lutio
nSo
dium
+ P
otas
sium
+ C
alci
um
131,
23 +
5,4
0 +
1,8
0 +
111
,73
+ C
hlor
ure
& L
actic
aci
d &
28,
50 m
mol
/l Po
che
Poch
e 50
0 m
l Pe
rfus
ion
solu
tion
Sodi
um C
hlor
ide
0,9%
, 2
ml
Inje
ctab
le S
olut
ion
Box
of 1
0 Pe
rfus
ion
solu
tion
& m
ediu
m fo
r IV
ther
apy
Sodi
um C
hlor
ide
9 m
g/10
ml
Inje
ctab
le S
olut
ion
Box
of 1
0 Pe
rfus
ion
solu
tion
& m
ediu
mSo
dium
Chl
orid
e 20
%/1
0ml
Inje
ctab
le S
olut
ion
Box
of 1
0 Pe
rfus
ion
solu
tion
& m
ediu
mSo
dium
Chl
orid
e 0,
9%
Infu
sion
bag
Po
che
of 2
50 m
l Pe
rfus
ion
Solu
tions
/ Io
nic
bala
nce
Sodi
um C
hlor
ide
0,9%
In
fusi
on b
ag
Poch
e of
500
/ 25
0 / 1
000
ml
Perf
usio
n So
lutio
ns /
Ioni
c ba
lanc
eSo
dium
Chl
orid
e 0,
9%
Infu
sion
bag
Po
che
of 5
0 m
l Pe
rfus
ion
Solu
tions
/ Io
nic
bala
nce
Sodi
um C
hlor
ide
0,9%
In
fusi
on b
ag
Poch
e of
100
ml
Perf
usio
n So
lutio
ns /
Ioni
c ba
lanc
eW
ater
for
inje
ctio
n 5
ml
Inje
ctio
n so
lutio
n B
ox o
f 10
IV m
ediu
m, s
olut
ion
for
dilu
tion
Wat
er fo
r in
ject
ion
10 m
l In
ject
ion
solu
tion
Box
of 1
0 IV
med
ium
, sol
utio
n fo
r di
lutio
nO
ther
s
Fent
anyl
0,
05 m
g/1m
l - 2
ml
Inje
ctab
le S
olut
ion
Box
of 1
0 M
orph
inic
ana
lges
ic
Apo
mor
phin
e C
hlor
hydr
ate
5 m
g/m
l In
ject
able
Sol
utio
n B
ox o
f 10
Ant
ipar
kins
on d
rug,
Dop
amin
ergi
c ag
onis
ts
(d
opam
iner
gic
rece
ptor
s st
imul
ator
)C
alci
um B
rom
ure
& C
alci
um L
acta
te
0,15
0 g
& 0
,4 g
/ am
poul
e D
rink
able
am
poul
e B
ox o
f 20
SED
ATIV
EM
idaz
olam
5
mg/
5ml
Inje
ctab
le S
olut
ion
Box
of 1
0 B
enzo
diaz
epin
ane
sthe
ticPa
pavé
rine
Chl
orhy
drat
e 40
mg/
2ml
Inje
ctab
le S
olut
ion
Box
of 1
0 A
ntis
pasm
odic
& N
on a
ntic
holin
ergi
cFl
avox
ate
HC
l 20
0 m
g Ta
blet
B
ox o
f 30
AN
TISP
ASM
OD
ICFE
XO
FEN
AD
INE
Stan
dby
Ant
ihis
tam
inic
H1
non
antic
holin
ergi
cA
rgin
ine
citr
at /
Bet
ain
/ Bet
ain
HC
l 1
g / 0
,5 g
/ 0.
5 g
Dri
nkab
le a
mpo
ule
Box
of 2
0 am
poul
es o
f 10
ml
Ant
iast
heni
a an
d A
nti h
epat
otro
pdi
lute
d ko
la T
inct
ure
/ Con
cent
rate
d ph
osph
oric
aci
d / M
anga
nese
G
lyce
roph
osph
ate
3,36
/ 0,
28 /
0,02
8 g
per
10m
l D
rink
able
am
poul
e B
ox o
f 30
ampo
ules
of 1
0 m
l A
ntia
sthe
nia
and
Ant
ifatig
uePi
race
tam
1
gr
Inje
ctab
le s
olut
ion
Box
e of
12
psyc
ostim
ulan
t & n
ootr
opic
SOTH
EMA
EX
PORT
LIS
TIN
N
D
osag
e Ph
arm
aceu
tical
For
m
Pres
enta
tion
Ther
apeu
tical
Cla
ssR
ecom
bina
nt H
uman
Insu
lin
100
UI
Inje
ctio
n V
ial o
f 10
ml
Hor
mon
e R
ecom
bina
nt H
uman
Insu
lin
100
UI
Inje
ctio
n V
ial o
f 10
ml
Hor
mon
e R
ecom
bina
nt H
uman
Insu
lin
100
UI
Inje
ctio
n V
ial o
f 10
ml
Hor
mon
e G
liben
clam
ide
5 m
g Ta
blet
s B
ox o
f 30
Ora
l ant
idia
bet &
hyp
ogly
cem
iant
sul
fam
ide
NSA
I, A
ntal
gic,
Ant
ipyr
etic
Ibup
rofe
n 40
0 m
g Ta
blet
B
ox o
f 30
AN
ALG
ESIC
- A
NTI
-IN
FLA
MM
ATO
RYIb
upro
fen
2%
Syru
p
AN
ALG
ESIC
- A
NTI
-IN
FLA
MM
ATO
RYC
arba
sala
te C
alci
c 10
0 m
g Sa
chet
B
ox o
f 20
AN
TIPY
RET
IC -
AN
TI IN
FLA
MAT
ORY
- A
NA
LGES
ICC
arba
sala
te C
alci
c 25
0 m
g Sa
chet
B
ox o
f 20
AN
TIPY
RET
IC -
AN
TI IN
FLA
MAT
ORY
- A
NA
LGES
ICC
arba
sala
te C
alci
c 50
0 m
g Sa
chet
B
ox o
f 20
AN
TIPY
RET
IC -
AN
TI IN
FLA
MAT
ORY
- A
NA
LGES
ICC
arba
sala
te C
alci
c 10
00 m
g Sa
chet
B
ox o
f 20
AN
TIPY
RET
IC -
AN
TI IN
FLA
MAT
ORY
- A
NA
LGES
ICIn
dom
etha
cin
& Is
osor
bide
Dim
ethy
l Eth
er
40 g
& 1
5g /
100
ml
Spra
y V
ial o
f 25
ml
AN
TI-I
NFL
AM
MAT
ORY
Mep
heno
n 10
mg/
1ml
Inje
ctab
le S
olut
ion
Box
of 1
0 Su
bstit
utio
n tr
eatm
ent
in
cas
e of
opi
ates
dep
ende
nce
Mor
phin
e
10 m
g/1m
l In
ject
able
Sol
utio
n B
ox o
f 10
Mor
phin
ic a
nata
lgic
Mor
phin
e
20 m
g/1m
l In
ject
able
Sol
utio
n B
ox o
f 10
Mor
phin
ic a
nata
lgic
Mor
phin
e
30 m
g/1m
l In
ject
able
Sol
utio
n B
ox o
f 10
Mor
phin
ic a
nata
lgic
Mor
phin
e +
Atr
opin
e 10
+0,
25 m
g/1m
l In
ject
able
Sol
utio
n B
ox o
f 10
Mor
phin
ic a
nata
lgic
FEN
OPR
OFE
N
300
mg
Tabl
et
Box
of 1
2 &
36
Ana
lges
icPA
RA
CET
AM
OL
+ C
AFF
EIN
E 50
0 m
g +
50
mg
Effe
rves
cent
Tab
let
Box
of 1
6 A
NA
LGES
IC -
AN
TIPY
RET
ICPA
RA
CET
AM
OL
+ C
AFF
EIN
E 50
0 m
g +
50
mg
Tabl
et
Box
of 1
6 A
NA
LGES
IC -
AN
TIPY
RET
ICPi
roxi
cam
inj
20 m
g/1m
l In
ject
able
Sol
utio
n B
ox o
f 2 &
6
NSA
IPi
roxi
cam
10
mg
Cap
sule
B
ox o
f 10
NSA
IPi
roxi
cam
20
mg
Cap
sule
B
ox o
f 10
& 2
8 N
SAI
Tram
adol
10
0 m
g/2m
l In
ject
able
Sol
utio
n B
ox o
f 5
Ana
lges
ic &
Opi
ate
Ago
nist
PIROXICAM
20mg,20/ml
Tablet,Injectionsolution
Boxof10,Boxof2and6ampoules
Anti-Inflamatory
Anx
ioly
tic
drug
s
Alp
razo
lam
0,
5 m
g Ta
blet
B
ox o
f 28
Anx
ioly
ticA
lpra
zola
m
1 m
g Ta
blet
B
ox o
f 14
Anx
ioly
ticH
ydro
xizi
ne 2
HC
l 10
0 m
g In
ject
able
sol
utio
n B
oxe
of 6
A
nxio
lytic
Ant
idep
ress
or d
rugs
Fluo
xetin
e 20
mg
Cap
sule
B
ox o
f 10,
20
& 3
0 A
NTI
DEP
RES
SAN
TSU
LPIR
IDE
100/
2 m
l In
ject
ion
solu
tion
Inje
ctab
le
Neu
role
ptic
SULP
IRID
E 50
mg
Cap
sule
s G
elul
es
Neu
role
ptic
Der
mat
olog
ical
dru
gs
Pa
ram
ethy
l Oxy
phen
ol
3 g
/ Tub
e O
intm
ent
Tub
e 30
g
CIC
ATR
ICIA
L M
ELA
NIC
DEP
IGM
ENTA
TIO
N A
GEN
TA
mm
oïdi
ne
10 m
g / T
able
t Ta
blet
B
ox o
f 30
AN
TIPS
OR
IATI
C /
loca
l Pho
toch
emot
hera
pyA
ntia
stm
a &
res
pira
tory
sti
mul
ant
drug
s
Caf
eine
50
mg/
5ml
Inje
ctab
le S
olut
ion
Box
of 1
0 C
entr
al r
espi
rato
ry s
timul
ant &
psy
chos
timul
ant
Theo
phyl
line
200
mg
Cap
sule
B
ox o
f 30
AN
TI-A
STH
MAT
IC (
XA
NTH
INE
DER
IVAT
ES)
Theo
phyl
line
300
mg
Cap
sule
B
ox o
f 60
AN
TI-A
STH
MAT
IC (
XA
NTH
INE
DER
IVAT
ES)
Theo
phyl
line
400
mg
Cap
sule
B
ox o
f 30
AN
TI-A
STH
MAT
IC (
XA
NTH
INE
DER
IVAT
ES)
Vit
amin
s &
Min
eral
s
Mul
tivita
min
, min
eral
sel
s &
Olig
o-
elem
ents
Effe
rves
cent
tabl
et
Box
of 1
0 Po
lyvi
tam
in, m
iner
als
& o
ligoe
lem
ent
Mag
nesi
um S
ulfa
t 7H
2O &
Yea
st
600
mg
& 5
0 m
g / C
apsu
le
Cap
sule
B
ox o
f 60
MA
GN
ESIU
M
Business Development SOTHEMA is a global pharmaceutical company operating in over 30 coun-tries worldwide. Our strategy is to ex-pand our presence in the global map with the support of enhanced market-ing and promotional system.
As of today, we operate in a variety of geographical locations through-out Europe, the Arab countries and sub-Saharan Africa.
Sothema will become more interna-tional in the coming years by pursu-ing a steady growth of its international subsidiaries
Our ProductsWe, at SOTHEMA, bank on the strength of our products range. Not only are they known for their quality and effica-cy, They are also our means of achiev-ing our end purpose of helping people lead healthier lives.
Certainly our various specialized prod-uct lines designed as per GMP require-ments, our production capacity and our strict implementation of the inter-national quality standards enable us to meet the need for manufacturing many complex therapeutic medica-tions of some national and multination-al laboratories.
Mr. Abdelillah CHEBIHIInternational Affairs Manager
Mr. Abdellah ABOURIDOUANEExport Manager
Tél. : +212 5 22 43 70 40Fax : +212 5 22 33 41 09
www.sothema.com
Contact InformationSOTHEMA is committed to provide ex-cellent products and superior service for our customers and business partners. If you would like additional company in-formation or would like to discuss part-nering opportunities please contact: